Australia PBS’s Biggest Expense, Statins, Called Overprescribed
This article was originally published in PharmAsia News
Executive Summary
Australia’s Pharmaceutical Benefits Scheme counts prescriptions for lowering cholesterol levels as its biggest expense, many of which are unnecessary, according to a new study.